Apr. 2 at 9:02 PM
$DCGO it's quite simple: 'not too much, not too little' I've followed DocGo since it dropped to 3$ back in the day (I think it was mainly due to news about the end of government contracts). I took advantage of the disappointment at the time, hoping the money from those contracts would still come through. Later on, it recovered to around
$5 and I sold. I pretty much forgot about it until now (I jumped back in before the Q3 results and didn't like the outlook, so I just got out the next day).
Now, things are just different. I got back in during Q4 (unfortunately, I didn't sell a single share the following day), but in this case, two fundamental things have changed: the company's price is discounting every shred of intrinsic value it's practically not even accounting for the cash on hand (continue)
